Fitstry review

There is a lot to like structurally — pharmacy partners named outright, a real certification, state coverage stated precisely rather than as a slogan, a named lab panel included, and a compounding disclosure that tells patients to check the concentration and beyond-use date on their own label. What there is not is a low-dose product. The catalog is standard-dose injectables and a daily tablet, so starting small means asking for less inside a standard plan at the standard plan's price. And the three product cards advertise entry prices the FAQ on the same page contradicts, on a cycle that bills every four weeks.

Vs median

Not comparable — billed per four weeks, which is thirteen charges a year rather than twelve, so it is not a monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Included

Labs

Required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Fitstry does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is required before you start. A clinician review is included in the price.

Fitstry is a funnel operated by Weightstry, LLC, described in its terms as a physician-led telehealth practice where clinical care is delivered by clinicians of an affiliated medical practice under a medical director. Entry is a free four-minute metabolic assessment that builds a profile for clinician review before any medication is recommended. It sells compounded semaglutide, compounded tirzepatide and daily GLP-1 tablets, with a named lab panel through a national laboratory, unlimited clinician messaging, a coach every two weeks and a 24/7 care line bundled in. Pharmacy partners are named openly. It is licensed in 49 states with one on a waitlist.

The three product cards advertise entry prices while the FAQ on the SAME PAGE puts the month-to-month rates at $249, $339 and $279 — the semaglutide headline understates its own standing rate by 67%, and the commitment length that would buy the advertised figure is disclosed nowhere

• Billing is every four weeks, not monthly — thirteen charges a year — while the FAQ describes the same charge as "a month"
• Sells no microdose or low-dose product at all, despite low-dose framing being a reason a reader would arrive
• The bundled-care framing is explicitly a limited-time promotion, so the labs, coaching and clinician access are not established as the ongoing offer
• The value assigned to that bundle is built from notional rates Fitstry assigned itself for services it has never charged for separately
• No milligram figures appear anywhere, so no price on the page can be tied to a dose
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Fitstry is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Oral semaglutide (Rybelsus)
• Is compounded GLP-1 safe?
• The true annual cost of a plan
• What a flat price costs at a low dose